HIIFS
BEAM icon

Harel Insurance Investments & Financial Services’s Beam Therapeutics BEAM Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53K Buy
+1,550
New +$46.8K ﹤0.01% 453
2021
Q1 		– Sell
-1,000
Closed -$263K – 744
2020
Q4 		$263K Buy
+1,000
New +$49.2K 0.01% 460

Other funds holding BEAM

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Harel Insurance Investments & Financial Services's BEAM Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services opened a new position in Beam Therapeutics (BEAM) in Q2 2026: 1,550 shares worth $53K. The stake represents ﹤0.01% of the portfolio and ranks #453 among its holdings. This is a return to the name: Harel Insurance Investments & Financial Services previously reported a position in BEAM as recently as Q4 2020.

Harel Insurance Investments & Financial Services first reported a position in BEAM in Q4 2020 and has held it in 2 quarters since. The position peaked at $263K in Q4 2020. 87 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 1,550 shares of Beam Therapeutics worth $53K as of Q2 2026.
  • Beam Therapeutics was a new Harel Insurance Investments & Financial Services position in Q2 2026.
  • Beam Therapeutics made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #453 holding.
  • Harel Insurance Investments & Financial Services first reported a position in Beam Therapeutics in Q4 2020 and has held it in 2 quarters since.
  • Harel Insurance Investments & Financial Services's Beam Therapeutics position peaked at $263K in Q4 2020.
  • 87 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.